Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose glucocorticoids versus replacement therapy for immune checkpoint inhibitor-associated hypophysitis
2017-001915-35Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Aug 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydrocortisone and prednisolone in hypophysitis (2 arms), sponsored by Medical University of Graz. Primary endpoints: Frequency of total hypophysitis resolution and Frequency of partial hypophysitis resolution. Started Aug 2017; status: completed.
02
Drugs
hydrocortisoneprednisolone
03
Conditions
hypophysitis
Beyond the preview
Go deeper on 2017-001915-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001915-35.